Advertisements



AbbVie says patients show improved RA symptoms in upadacitinib trials

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2019

Novartis: follow-up data from ENESTfreedom, ENESTop trials show sustained TFR

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 14th, 2019

AbbVie"s Skyrizi And Upadacitinib May Not Be Enough To Offset Humira Declines

AbbVie"s Skyrizi And Upadacitinib May Not Be Enough To Offset Humira Declines.....»»

Category: topSource: seekingalphaJun 3rd, 2019

UN Torture Expert: Assange Showing Symptoms Of "Intense Psychological Trauma"

WikiLeaks founder Julian Assange is suffering from "intense psychological trauma" in a British prison and should not be extradited to the United Sates to face a "politicized show trial," according to a UN human rights investigator.Â.....»»

Category: blogSource: zerohedgeMay 31st, 2019

AbbVie halts enrollment after brain cancer trial misses goal, shares fall

AbbVie Inc said on Friday it has halted enrollment of patients in all ongoing studies testing its brain cancer treatment after the drug failed to meet the main goal in a late-stage trial......»»

Category: topSource: reutersMay 17th, 2019

Iovance Bio’s Big Break in Cervical Cancer Ahead of ASCO

Iovance Biotherapeutics is one of the early big winners from ASCO. The firm announced updates from ongoing clinical trials including new interim data from studies of patients with advanced cervical........»»

Category: blogSource: 247wallstMay 16th, 2019

AbbVie working with MC10 on MS clinical trials using BioStamp nPoint system

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 14th, 2019

Momenta Pharmaceuticals Reports First Quarter 2019 Financial and Operating Results

— M281 Phase 2 trials in MG and HDFN active and enrolling patients — — Data supporting M281's m.....»»

Category: earningsSource: benzingaMay 2nd, 2019

5 warning signs of a brain tumor

As patients, we each play an important role in our own health care. Knowing your symptoms as they develop and talking to your physician early on, helps determine the best course of action for you. This is certainly important when dealing with tumors in.....»»

Category: topSource: bizjournalsMay 1st, 2019

Beaten-down health-care companies join Apple and Google in earnings parade

The health-care sector hit a rough patch this month, and now the companies have to show if they have any negative symptoms......»»

Category: topSource: marketwatchApr 29th, 2019

Medical trials at Aurora Research Institute uncover lifesaving news for leukemia patients

Medical trials at Aurora Research Institute uncover lifesaving news for leukemia patients.....»»

Category: topSource: bizjournalsApr 29th, 2019

Merck"s Keytruda no better than chemo as a first-line treatment for gastric cancer, according to Phase 3 study results

Merck & Co. Inc. said Friday that a Phase 3 trial evaluating Keytruda as a first-line treatment for gastric cancer failed to show improvement in patients' overall or progression-free survival when compared with chemotherapy. Shares of th.....»»

Category: topSource: marketwatchApr 26th, 2019

Getinge Publishes Interim Report for January-March 2019

GOTHENBURG, Sweden, April 23, 2019 /PRNewswire/ -- "We show strong organic growth and improved operating margin in the first quarter", says Mattias Perjos, President & CEO Geti.....»»

Category: earningsSource: benzingaApr 23rd, 2019

How free-flowing cash is accelerating small companies" cancer drug trials

An unprecedented biotech investment boom means smaller companies can accelerate early-stage drug trials and, potentially, carry them to more patients faster......»»

Category: topSource: bizjournalsApr 8th, 2019

Nationwide Children"s spinoff raises $14M toward software to catch cancer sooner

A Nationwide Children's Hospital spinoff that uses artificial intelligence to speed cancer diagnosis and match patients to clinical trials has raised $14 million, the largest Central Ohio round of the year so far. Deep Lens Inc. raised the series A ro.....»»

Category: topSource: bizjournalsApr 8th, 2019

BRIC PMIs For March Show Improved Growth Conditions

BRIC PMIs For March Show Improved Growth Conditions.....»»

Category: topSource: seekingalphaApr 5th, 2019

PolarityTE enrolls patients in trials evaluating SkinTE

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 1st, 2019

Biogen stock plummets 28% after company halts Alzheimer’s trials

Shares of pharmaceutical giant Biogen Inc. plunged 28% on Thursday morning after the drugmaker said it would discontinue its Phase 3 trials of aducanumab, an investigational drug designed to treat symptoms of early Alzheimer’s disease......»»

Category: topSource: marketwatchMar 24th, 2019

Biogen stock plummets 28% after halting Alzheimer’s trials

Shares of pharmaceutical giant Biogen Inc. plunged 28% on Thursday morning after the drugmaker said it would discontinue its Phase 3 trials of aducanumab, an investigational drug designed to treat symptoms of early Alzheimer’s disease......»»

Category: topSource: marketwatchMar 21st, 2019

Biogen shares, Alzheimer"s patients hopes sink after Phase 3 trials fail

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 21st, 2019

Bad News for AbbVie and Multiple Myeloma Patients

AbbVie and patients suffering from multiple myeloma have seen some additional bad news from the FDA......»»

Category: blogSource: 247wallstMar 19th, 2019